Loading clinical trials...

A Phase 2 Study to Describe the Safety and Immunogenicity of Respiratory Syncytial Virus Vaccine IN006 in Healthy Participants Aged 60 Years and Older | Clinical Trials | Clareo Health

Active Not RecruitingPhase 2

A Phase 2 Study to Describe the Safety and Immunogenicity of Respiratory Syncytial Virus Vaccine IN006 in Healthy Participants Aged 60 Years and Older

A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Immunogenicity of the Respiratory Syncytial Virus IN006 Bivalent mRNA Vaccine (IN006) in Healthy Participants Aged 60 Years and Older

NCT07128121•Shenzhen Shenxin Biotechnology Co., Ltd

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Respiratory Syncytial Virus (RSV) Infection

Interventions

Respiratory Syncytial Virus IN006 Bivalent mRNA Vaccine (IN006)

Placebo

Locations

1

China

Locations (1)

Hunan Provincial Center for Disease Control and Prevention

Changsha, Hunan, China

Key Dates

Start Date

August 13, 2025

Primary Completion Date

October 1, 2029

Completion Date

October 1, 2029

Last Updated

September 9, 2025

Related Studies

In-depth Analysis of the Immune Responses in the Upper Respiratory Tract in Older Adults Infected or Colonized With Streptococcus Pneumoniae (Spn)

NCT06998251

Pneumococcal InfectionsRespiratory Syncytial Virus (RSV) Infection+1 more

COMPLETEDPhase 2

Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study

NCT02718937

Respiratory Syncytial Virus (RSV) Infection

Sponsors

Lead Sponsor

Shenzhen Shenxin Biotechnology Co., Ltd

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 9, 2025Data synced to Clareo: April 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions